Current status and prospects of treatment of newly-diagnosed nasopharyngeal carcinoma with distant metastasis
10.3760/cma.j.cn113030-20200206-00048
- VernacularTitle:初治远处转移鼻咽癌的治疗现状与展望
- Author:
Mengshan NI
1
;
Hongmei YING
Author Information
1. 复旦大学附属肿瘤医院放射治疗中心 复旦大学上海医学院肿瘤学系 上海市放射肿瘤学重点实验室 200032
- Keywords:
Nasopharyngeal neoplasm/chemotherapy;
Nasopharyngeal neoplasm/radiotherapy;
Neoplasm metastasis
- From:
Chinese Journal of Radiation Oncology
2021;30(9):979-983
- CountryChina
- Language:Chinese
-
Abstract:
From synchronous metastasis to metachronous metastasis and from oligometastasis to disseminated metastasis, distant metastatic nasopharyngeal carcinoma (stage IV B) has great heterogeneity. The prognosis of stage IV B nasopharyngeal carcinoma patients with distant metastases is closely related to the anatomical characteristics of metastases. Therefore, it is necessary to subdivide M 1 stage to lay the foundation for individualized treatment of patients with metastatic nasopharyngeal carcinoma. In addition to systemic chemotherapy, the primary tumors and metastatic lesions should be considered during the treatment of newly-diagnosed metastatic nasopharyngeal carcinoma. Currently, there is a lack of recognized treatment modes for newly-diagnosed stageⅣ B nasopharyngeal carcinoma, and more studies are needed to evaluate the clinical benefits of different treatment methods.
